Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 10/20 | 0.78 |
| ▸ | MEN1 | O00255 | 9/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.78 |
| ▸ | ABCB1 | P08183 | 8/20 | 0.78 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.78 |
| ▸ | MAPT | P10636 | 7/20 | 0.78 |
| ▸ | CYP2C9 | P11712 | 7/20 | 0.78 |
| ▸ | CYP1A2 | P05177 | 7/20 | 0.78 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.78 |
| ▸ | POLH | Q9Y253 | 6/20 | 0.78 |
| ▸ | XDH | P47989 | 6/20 | 0.78 |
| ▸ | FTO | Q9C0B1 | 6/20 | 0.78 |
| ▸ | TP53 | P04637 | 6/20 | 0.78 |
| ▸ | ALOX15 | P16050 | 6/20 | 0.78 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.78 |
| ▸ | CYP1A1 | P04798 | 5/20 | 0.78 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.78 |
| ▸ | HPGD | P15428 | 5/20 | 0.78 |
| ▸ | DAPK1 | P53355 | 5/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30684642 | 1.00 | CYP3A4 (0.78) | CYP3A4MEN1KMT2AABCB1KDM4E | |
| SCHEMBL29664378 | 0.88 | POLH (0.79) | CYP3A4MEN1KMT2AABCB1KDM4E | |
| Kaempferol SCHEMBL29378805 | 0.88 | MEN1 (1.00) | CYP3A4MEN1KMT2AABCB1KDM4E | |
| Kaempferol SCHEMBL18817 | 0.88 | MEN1 (1.00) | CYP3A4MEN1KMT2AABCB1KDM4E | |
| Kaempferol SCHEMBL1259228 | 0.88 | MEN1 (1.00) | CYP3A4MEN1KMT2AABCB1KDM4E | |
| Kaempferol SCHEMBL30655455 | 0.88 | MEN1 (1.00) | CYP3A4MEN1KMT2AABCB1KDM4E | |
| Kaempferol SCHEMBL31577746 | 0.86 | MEN1 (0.97) | CYP3A4MEN1KMT2AABCB1KDM4E | |
| Kaempferol SCHEMBL31256029 | 0.86 | MEN1 (0.97) | CYP3A4MEN1KMT2AABCB1KDM4E | |
| Kaempferol SCHEMBL17237761 | 0.86 | MEN1 (0.97) | CYP3A4MEN1KMT2AABCB1KDM4E | |
| Kaempferol SCHEMBL34461912 | 0.86 | MEN1 (0.97) | CYP3A4MEN1KMT2AABCB1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220387534-A1 | ANTIOXIDANT AND ANTIMICROBIAL COMPOSITIONS AND METHODS OF USING THEM TO PROTECT SKIN OR TREAT OR PREVENT INFECTIONS | PETKOSKA ANKA T (MK) | 2022-12-08 | — | — | US | claimed |
| WO-2009087568-A2 | COMPOSITIONS COMPRISING ANTIOXIDANT AND MITOPROTECTIVE FLAVONOIDS WITH NEUROPROTECTIVE PROPERTIES | UNIVERSIDADE DE COIMBRA (PT) | 2009-07-16 | — | — | WO | claimed |
| US-20010036486-A1 | Method for treating nicotine addiction and deterring tobacco use with hypericum perforatum | ROSENTHAL NORMAN E (US) | 2001-11-01 | — | — | US | claimed |
| EP-3391880-B1 | NEDDYLATION INHIBITOR FOR USE IN PREVENTING OR TREATING OSTEOPOROSIS | UNIV CHANG GUNG (TW) | 2023-06-07 | — | — | EP | disclosed |
| US-20220387534-A1 | ANTIOXIDANT AND ANTIMICROBIAL COMPOSITIONS AND METHODS OF USING THEM TO PROTECT SKIN OR TREAT OR PREVENT INFECTIONS | PETKOSKA ANKA T (MK) | 2022-12-08 | — | — | US | disclosed |
| EP-3466930-B1 | REDUCED SODIUM FOOD PRODUCT | GEN MILLS INC (US) | 2022-07-20 | — | — | EP | disclosed |
| US-20210252160-A1 | COMPOUNDS, COMPOSITIONS, METHODS, AND USES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS | IL-2RX | 2021-08-19 | — | — | US | disclosed |
| US-20200281236-A1 | REDUCED SODIUM FOOD PRODUCTS | GEN MILLS INC (US) | 2020-09-10 | — | — | US | disclosed |
| EP-3466930-A1 | REDUCED SODIUM FOOD PRODUCT | GENERAL MILLS, INC. (US) | 2019-04-10 | — | — | EP | disclosed |
| US-20190090520-A1 | REDUCED SODIUM FOOD PRODUCTS | GEN MILLS INC (US) | 2019-03-28 | — | — | US | disclosed |
| US-10159268-B2 | Reduced sodium food products | GENERAL MILLS, INC. (US) | 2018-12-25 | — | — | US | disclosed |
| WO-2000030660-A2 | HYPERFORIN AS CYTOSTATIC AGENT AND HYPERFORIN OINTMENT OR CREAM AS APPLICATION FORM | Universitätsklinikum Freiburg (DE) | 2000-06-02 | — | — | WO | disclosed |
| WO-2000023089-A1 | NATURAL FORMULATION FOR THE TREATMENT AND PREVENTION OF DEPRESSION, CONTAINING ST JOHN'S WORT AND DERIVATIVES OF DIHYDRO- AND TETRAHYDROFOLIC ACID | MERCK PATENT GMBH (DE) | 2000-04-27 | — | — | WO | disclosed |
| US-5948918-A | PLANT EXTRACTS | MEDICHEM RESEARCH, INC. (US) | 1999-09-07 | — | — | US | disclosed |
| WO-1998046238-A1 | BIFLAVINOIDS AND DERIVATIVES THEREOF AS ANTIVIRAL AGENTS, ALONE OR IN COMBINATION WITH AT LEAST ONE KNOWN ANTIVIRAL AGENT | MEDICHEM RESEARCH, INC. (US) | 1998-10-22 | — | — | WO | disclosed |
| EP-0599307-B1 | St.-John's-wort dry extract, process for its preparation and its use | SCHWABE WILLMAR GMBH & CO (DE) | 1998-08-26 | — | — | EP | disclosed |
| US-5773462-A | INFLUENZA THERAPY | MEDICHEM RESEARCH, INC. (US) | 1998-06-30 | — | — | US | disclosed |
| EP-0833631-A1 | BIFLAVANOIDS AND DERIVATIVES THEREOF AS ANTIVIRAL AGENTS | MEDICHEM RESEARCH, INC. (US) | 1998-04-08 | — | — | EP | disclosed |
| WO-1997000679-A1 | BIFLAVANOIDS AND DERIVATIVES THEREOF AS ANTIVIRAL AGENTS | MEDICHEM RESEARCH, INC. (US) | 1997-01-09 | — | — | WO | disclosed |
| EP-0599307-A1 | St.-John's-wort dry extract, process for its preparation and its use | Dr. Willmar Schwabe GmbH & Co. (DE) | 1994-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210252160-A1 | COMPOUNDS, COMPOSITIONS, METHODS, AND USES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS | TNFRSF9, EGFR, NGFR | CYP3A4 4486/4885MEN1 575/4885KMT2A 2549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.